Optimization of hyaluronan-enriched cubosomes for bromfenac delivery enhancing corneal permeation: characterization, ex vivo, and in vivo evaluation

References

• Abd-Elsalam WH, Ibrahim RR. (2021). Span 80/TPGS modified lipid-coated chitosan nanocomplexes of acyclovir as a topical delivery system for viral skin infections. Int J Pharm 609:1.
   Google Scholar
• Abdelbary AA, Abd-Elsalam WH, Al-Mahallawi AM. (2016). Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: in vitro characterization, ex vivo permeation and in vivo safety assessment. Int J Pharm 513:688–13.
   PubMed Web of Science ®Google Scholar
• Abdellatif MM, Josef M, El-Nabarawi MA, Teaima M. (2022). Sertaconazole-nitrate-loaded leciplex for treating keratomycosis: optimization using D-optimal design and in vitro, ex vivo, and in vivo studies. Pharmaceutics 14:2215.
   PubMed Web of Science ®Google Scholar
• Abdou EM, Fayed MA, Helal D, Ahmed KA. (2019). Assessment of the hepatoprotective effect of developed lipid-polymer hybrid nanoparticles (LPHNPs) encapsulating naturally extracted β-Sitosterol against CCl4 induced hepatotoxicity in rats. Sci Rep 9:1–14.
   PubMed Web of Science ®Google Scholar
• Akhter MH, Ahmad I, Alshahrani MY, et al. (2022). Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System. Gels 8:82.
   PubMed Web of Science ®Google Scholar
• Al-Mahallawi AM, Abdelbary AA, El-Zahaby S. (2021). Norfloxacin loaded nano-cubosomes for enhanced management of otitis externa: in vitro and in vivo evaluation. Int J Pharm 600:120490.
   PubMed Web of Science ®Google Scholar
• Albash R, El-Nabarawi MA, Refai H, Abdelbary AA. (2019). Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment. Int J Nanomedicine 14:6555–74.
   PubMed Web of Science ®Google Scholar
• Ang BCH, Sng JJ, Wang PXH, et al. (2017). Sodium hyaluronate in the treatment of dry eye syndrome: a systematic review and meta-analysis. Sci Rep 7:9013.
   PubMed Web of Science ®Google Scholar
• Ángeles GH, Nešporová K. (2021). Hyaluronan and its derivatives for ophthalmology: recent advances and future perspectives. Carbohydr Polym 259:117697.
   PubMed Web of Science ®Google Scholar
• Barkat MA, Das SS, Pottoo FH, et al. (2020). Lipid-based nanosystem as intelligent carriers for versatile drug delivery applications. Curr Pharm Des 26:1167–80.
   PubMed Web of Science ®Google Scholar
• Bei D, Zhang T, Murowchick JB, Youan BB. (2010). Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization. AAPS PharmSciTech 11:1243–9.
   PubMed Web of Science ®Google Scholar
• Cable M. (2012). Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single site. Clinical Ophthalmology 6:997.
   PubMedGoogle Scholar
• Cagini C, Torroni G, Mariniello M, et al. (2021). Trehalose/sodium hyaluronate eye drops in post-cataract ocular surface disorders. Int Ophthalmol 41:3065–71.
   PubMed Web of Science ®Google Scholar
• Chávez-Mondragón E, Palacio C, Soto-Gómez A, et al. (2019). Efficacy and safety of bromfenac 0.09% and sodium hyaluronate 0.4% combination therapy, versus placebo in patients with pterygium I–III for clinical signs on ocular inflammation. Clin Ophthalmol 13:781–7.
   PubMed Web of Science ®Google Scholar
• Chong JY, Mulet X, Boyd BJ, Drummond CJ. (2015). Steric stabilizers for cubic phase lyotropic liquid crystal nanodispersions (cubosomes). Advances in Planar Lipid Bilayers and Liposomes 21:131–87.
   Google Scholar
• Eldeeb AE, Salah S, Ghorab M. (2019). Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: ex-vivo permeation and in-vivo pharmacodynamic study. J Drug Delivery Sci Technol 52:236–47.
   Web of Science ®Google Scholar
• Elnaggar YS, Etman SM, Abdelmonsif DA, Abdallah OY. (2015). Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer’s disease: pharmaceutical, biological, and toxicological studies. Int J Nanomedicine 10:5459–73.
   PubMed Web of Science ®Google Scholar
• Fahmy AM, Hassan M, El-Setouhy DA, et al. (2021). Statistical optimization of hyaluronic acid enriched ultradeformable elastosomes for ocular delivery of voriconazole via Box-Behnken design: in vitro characterization and in vivo evaluation. Drug Deliv 28:77–86.
   PubMed Web of Science ®Google Scholar
• Fezza JP. (2018). Cross-linked hyaluronic acid gel occlusive device for the treatment of dry eye syndrome. Clin Ophthalmol 12:2277–83.
   PubMed Web of Science ®Google Scholar
• Fouda NH, Abdelrehim RT, Hegazy DA, Habib BA. (2018). Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits. Drug Deliv 25:1340–9.
   PubMed Web of Science ®Google Scholar
• Fujishima H, Fuseya M, Ogata M, Murat D. (2015). Efficacy of bromfenac sodium ophthalmic solution for treatment of dry eye disease. Asia Pac J Ophthalmol (Phila) 4:9–13.
   PubMedGoogle Scholar
• Gaballa SA, El Garhy OH, Abdelkader H. (2020). Cubosomes: composition, preparation, and drug delivery applications. Journal of Advanced Biomedical and Pharmaceutical Sciences 3:1–9.
   Google Scholar
• Gade S, Patel KK, Gupta C, et al. (2019). An ex vivo evaluation of moxifloxacin nanostructured lipid carrier enriched in situ gel for transcorneal permeation on goat cornea. J Pharm Sci 108:2905–16.
   PubMed Web of Science ®Google Scholar
• Garg M, Goyal A, Kumari S. (2021). An update on the recent advances in cubosome: a novel drug delivery system. Curr Drug Metab 22:441–50.
   PubMed Web of Science ®Google Scholar
• Hakeem EA, El-Mahrouk GM, Abdelbary G, Teaima MH. (2020). Freeze-dried clopidogrel loaded lyotropic liquid crystal: box-Behnken optimization, in-vitro and in-vivo evaluation. Curr Drug Deliv 17:207–17.
   PubMed Web of Science ®Google Scholar
• Han S, Shen JQ, Gan Y, et al. (2010). Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability. Acta Pharmacol Sin 31:990–8.
   PubMed Web of Science ®Google Scholar
• Hoffman RS, Braga-Mele R, Donaldson K, ASCRS Cataract Clinical Committee and the American Glaucoma Society, et al. (2016). Cataract surgery and nonsteroidal antiinflammatory drugs. J Cataract Refract Surg 42:1368–79.
   PubMed Web of Science ®Google Scholar
• Hosny KM. (2020). Nanosized cubosomal thermogelling dispersion loaded with saquinavir mesylate to improve its bioavailability: preparation, optimization, in vitro and in vivo evaluation. Int J Nanomedicine 15:5113–29.
   PubMed Web of Science ®Google Scholar
• Huang J, Peng T, Li Y, et al. (2017). Ocular cubosome drug delivery system for timolol maleate: preparation, characterization, cytotoxicity, ex vivo, and in vivo evaluation. AAPS PharmSciTech 18:2919–26.
   PubMed Web of Science ®Google Scholar
• Hundekar YR, Saboji J, Patil S, Nanjwade B. (2014). Preparation and evaluation of diclofenac sodium cubosomes for percutaneous administration. World Journal of Pharmacy and Pharmaceutical Sciences 3:523–39.
   Google Scholar
• Huynh A, Priefer R. (2020). Hyaluronic acid applications in ophthalmology, rheumatology, and dermatology. Carbohydr Res 489:107950.
   PubMed Web of Science ®Google Scholar
• Kamel AE, Fadel M, Louis D. (2019). Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line. Int J Nanomedicine 14:5073–85.
   PubMed Web of Science ®Google Scholar
• Khan MM, Madni A, Torchilin V, Filipczak N, et al. (2019). Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin. Drug Deliv 26:765–72.
   PubMed Web of Science ®Google Scholar
• Kiran BSS, Raja S. (2018). A novel analytical method development and validation for the estimation of Bromfenac sodium by using reverse phase-HPLC. The Pharma Innovation International Journal 7:569–73.
   Google Scholar
• Kutbi HI, Asfour HZ, Kammoun AK, et al. (2021). Optimization of Hyaluronate-Based Liposomes to Augment the Oral Delivery and the Bioavailability of Berberine. Materials 14:5759.
   PubMed Web of Science ®Google Scholar
• Lai J, Lu Y, Yin Z, et al. (2010). Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles. Int J Nanomedicine 5:13–23.
   PubMed Web of Science ®Google Scholar
• Lewis GA, Mathieu D, Phan-Tan-Luu R. 1998. Pharmaceutical experimental design. Boca Raton, FL: CRC press.
   Google Scholar
• Li Z, Guo R, Gu Z, et al. (2019). Identification of a promoter element mediating kisspeptin-induced increases in GnRH gene expression in sheep. Gene 699:1–7.
   PubMed Web of Science ®Google Scholar
• Mohamed HB, Attia Shafie MA, Mekkawy AI. (2022). Chitosan nanoparticles for meloxicam ocular delivery: development, in vitro characterization, and in vivo evaluation in a rabbit eye model. Pharmaceutics 14:893.
   PubMedGoogle Scholar
• Mohyeldin SM, Mehanna MM, Elgindy NA. (2016). Superiority of liquid crystalline cubic nanocarriers as hormonal transdermal vehicle: comparative human skin permeation-supported evidence. Expert Opin Drug Deliv 13:1049–64.
   PubMed Web of Science ®Google Scholar
• Muller F, Salonen A, Glatter O. (2010). Phase behavior of Phytantriol/water bicontinuous cubic Pn3m cubosomes stabilized by Laponite disc-like particles. J Colloid Interface Sci 342:392–8.
   PubMed Web of Science ®Google Scholar
• Naguib MJ, Hassan YR, Abd-Elsalam WH. (2021). 3D printed ocusert laden with ultra-fluidic glycerosomes of ganciclovir for the management of ocular cytomegalovirus retinitis. Int J Pharm 607:121010.
   PubMedGoogle Scholar
• Nair AB, Shah J, Al-Dhubiab BE, et al. (2021). Clarithromycin solid lipid nanoparticles for topical ocular therapy: optimization, evaluation and in vivo studies. Pharmaceutics 13:523.
   PubMed Web of Science ®Google Scholar
• Nasr M, Ghorab MK, Abdelazem A. (2015). In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting. Acta Pharm Sin B 5:79–88.
   PubMed Web of Science ®Google Scholar
• Nasr M, Teiama M, Ismail A, et al. (2020). In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole in treatment of keratomycosis. Drug Deliv Transl Res 10:1841–52.
   PubMed Web of Science ®Google Scholar
• Nawaz T, Iqbal M, Khan BA, et al. (2021). Development and Optimization of Acriflavine-Loaded Polycaprolactone Nanoparticles Using Box–Behnken Design for Burn Wound Healing Applications. Polymers 14:101.
   PubMed Web of Science ®Google Scholar
• Nazaruk E, Majkowska-Pilip A, Bilewicz R. (2017). Lipidic cubic-phase nanoparticles—cubosomes for efficient drug delivery to cancer cells. ChemPlusChem 82:570–5.
   PubMed Web of Science ®Google Scholar
• Pal SL, Jana U, Manna PK, Mohanta GP, Manavalan R. (2011). Nanoparticle: an overview of preparation and characterization. J Appl Pharm Sci 1:228–34.
   Google Scholar
• Rarokar NR, Saoji SD, Raut NA, et al. (2016). Nanostructured cubosomes in a thermoresponsive depot system: an alternative approach for the controlled delivery of docetaxel. AAPS PharmSciTech 17:436–45.
   PubMed Web of Science ®Google Scholar
• Rizwan SB, McBurney WT, Young K, et al. (2013). Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses. J Control Release 165:16–21.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Panyam J, Prabha S, Labhasetwar V. (2002). Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 82:105–14.
   PubMed Web of Science ®Google Scholar
• Salah S, Mahmoud AA, Kamel AO. (2017). Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies. Drug Deliv 24:846–56.
   PubMed Web of Science ®Google Scholar
• Sayed S, Abdel-Moteleb M, Amin MM, Khowessah OM. (2021). Cubogel as potential platform for glaucoma management. Drug Deliv 28:293–305.
   PubMed Web of Science ®Google Scholar
• Sherif S, Bendas ER, Badawy S. (2014). The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle. Eur J Pharm Biopharm 86:251–9.
   PubMed Web of Science ®Google Scholar
• Soleimani F, Madaah Hosseini HR, Ordikhani F, et al. (2016). Enhancing sonocatalytic properties of TiO2 nanocatalysts by controlling the surface conditions: effect of particle size and PVA modification. Desalination 57:28378–85.
   Web of Science ®Google Scholar
• Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. (2013). Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int J Pharm 443:293–305.
   PubMed Web of Science ®Google Scholar
• Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. (2016). Duodenum-triggered delivery of pravastatin sodium: II. Design, appraisal and pharmacokinetic assessments of enteric surface-decorated nanocubosomal dispersions. Drug Deliv 23:3266–78.
   PubMed Web of Science ®Google Scholar
• Thomas L, Viswanad V. (2012). Formulation and optimization of clotrimazole-loaded proniosomal gel using 32 factorial design. Sci Pharm 80:731–48.
   PubMedGoogle Scholar
• Tomoda K, Chiang C, Kozak KR, Kwon G. (2015). Examination of gossypol-pluronic micelles as potential radiosensitizers. Aaps J 17:1369–75.
   PubMed Web of Science ®Google Scholar
• Tran TH, Choi JY, Ramasamy T, et al. (2014). Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells. Carbohydr Polym 114:407–15.
   PubMed Web of Science ®Google Scholar
• Vasanth S, Dubey A, G SR, et al. (2020). Development and Investigation of Vitamin C-Enriched Adapalene-Loaded Transfersome Gel: a Collegial Approach for the Treatment of Acne Vulgaris. AAPS PharmSciTech 21:61.
   PubMed Web of Science ®Google Scholar
• Vo A, Feng X, Patel D, et al. (2020). Factors affecting the particle size distribution and rheology of brinzolamide ophthalmic suspensions. Int J Pharm 586:119495.
   PubMedGoogle Scholar
• Wadhwa S, Paliwal R, Paliwal SR, Vyas SP. (2010). Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation. J Drug Target 18:292–302.
   PubMed Web of Science ®Google Scholar
• Wörle G, Drechsler M, Koch MH, et al. (2007). Influence of composition and preparation parameters on the properties of aqueous monoolein dispersions. Int J Pharm 329:150–7.
   PubMed Web of Science ®Google Scholar
• Xing Y, Zhu L, Zhang K, et al. (2021). Nanodelivery of triamcinolone acetonide with PLGA-chitosan nanoparticles for the treatment of ocular inflammation. Artif Cells Nanomed Biotechnol 49:308–16.
   PubMed Web of Science ®Google Scholar
• Younes NF, Abdel-Halim SA, Elassasy AI. (2018). Corneal targeted Sertaconazole nitrate loaded cubosomes: preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies. Int J Pharm 553:386–97.
   PubMed Web of Science ®Google Scholar
• Zamboni F, Vieira S, Reis RL, et al. (2018). The potential of hyaluronic acid in immunoprotection and immunomodulation: chemistry, processing and function. Prog Mater Sci 97:97–122.
   Web of Science ®Google Scholar